Tebentafusp in first-line melanoma trials: An outperforming outlier

Olivier, T; Prasad, V

Olivier, T (通讯作者),Geneva Univ Hosp, Dept Oncol, 4 Gabrielle Perret Gentil St, CH-1205 Geneva, Switzerland.

TRANSLATIONAL ONCOLOGY, 2022; 20 ():

Abstract

Uveal melanoma is distinct from other melanomas. In the advanced and metastatic stages, little to no improvement have been seen over time. Tebentafusp......

Full Text Link